Retrospective study of adjuvant icotinib in postoperative lung cancer patients harboring epidermal growth factor receptor mutations

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations occur in about 50% of Asian patients with non‐small cell lung cancer (NSCLC). Patients with advanced NSCLC and EGFR mutations derive clinical benefit from treatment with EGFR‐tyrosine kinase inhibitors (TKIs). This study assessed the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Shuyang, Zhi, Xiuyi, Wang, Ruotian, Qian, Kun, Hu, Mu, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130296/
https://www.ncbi.nlm.nih.gov/pubmed/27766784
http://dx.doi.org/10.1111/1759-7714.12365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130296/
https://www.ncbi.nlm.nih.gov/pubmed/27766784
http://dx.doi.org/10.1111/1759-7714.12365

Ejemplares similares